(NASDAQ: ATON) Alphaton Capital's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 12%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 36.33%.
Alphaton Capital's earnings in 2026 is -$14,894,000.On average, 3 Wall Street analysts forecast ATON's earnings for 2026 to be -$3,043,966, with the lowest ATON earnings forecast at -$2,924,594, and the highest ATON earnings forecast at -$3,133,494. On average, 3 Wall Street analysts forecast ATON's earnings for 2029 to be -$58,538, with the lowest ATON earnings forecast at -$56,242, and the highest ATON earnings forecast at -$60,260.
In 2030, ATON is forecast to generate $760,991 in earnings, with the lowest earnings forecast at $731,149 and the highest earnings forecast at $783,374.